• 1
    Ham TH,Dingle JH. Studies on destruction of red blood cells. Ii. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: Certain immunological aspects of the hemolytic mechanism with special reference to serum complement. J Clin Invest 1939; 18: 657672.
  • 2
    Hall SE,Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 53325340.
  • 3
    Kanamaru A,Okuda K,Ueda E,Kitani T,Kinoshita T,Nagai K. Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Blood 1988; 72: 507511.
  • 4
    Schubert J,Alvarado M,Uciechowski P,Zielinska-Skowronek M,Freund M,Vogt H,Schmidt RE. Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 1991; 79: 487492.
  • 5
    van der Schoot CE,Huizinga TW,van't Veer-Korthof ET,Wijmans R,Pinkster J,von dem Borne AE. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 1990; 76: 18531859.
  • 6
    Diep DB,Nelson KL,Raja SM,Pleshak EN,Buckley JT. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem 1998; 273: 23552360.
  • 7
    Brodsky RA,Mukhina GL,Li S,Nelson KL,Chiurazzi PL,Buckley JT,Borowitz MJ. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000; 114: 459466.
  • 8
    Brodsky RA,Mukhina GL,Nelson KL,Lawrence TS,Jones RJ,Buckley JT. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood 1999; 93: 17491756.
  • 9
    Sutherland DR,Kuek N,Davidson J,Barth D,Chang H,Yeo E,Bamford S,Chin-Yee I,Keeney M. Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B Clin Cyto 2007; 72B: 167177.
  • 10
    Hernandez-Campo PM,Martin-Ayuso M,Almeida J,Lopez A,Orfao A. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets. Cytometry 2002; 50: 191201.
  • 11
    Sutherland DR,Kuek N,Azcona-Olivera J,Anderson T,Acton E,Barth D,Keeney M. Use of a FLAER-based WBC assay in the primary screening of PNH clones. Am J Clin Pathol 2009; 132: 564572.
  • 12
    Maecker HT,Frey T,Nomura LE,Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry A 2004; 62A: 169173.
  • 13
    Peghini PE,Fehr J. Clinical evaluation of an aerolysin-based screening test for paroxysmal nocturnal haemoglobinuria. Cytometry B Clin Cyt 2005; 67B: 1318.
  • 14
    Scheinberg P,Wu CO,Nunez O,Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 2009; 144: 206216.
  • 15
    Nakao S,Sugimori C,Yamazaki H. Clinical significance of a small population of paroxysmal nocturnal hemoglobinuria-type cells in the management of bone marrow failure. Int J Hematol 2006; 84: 118122.
  • 16
    Sugimori C,Chuhjo T,Feng X,Yamazaki H,Takami A,Teramura M,Mizoguchi H,Omine M,Nakao S. Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 2006; 107: 13081314.
  • 17
    Ho AD,Maruyama M,Maghazachi A,Mason JR,Gluck S,Corringham RE. Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation. Blood 1994; 84: 35503557.
  • 18
    Matsuda Y,Hara J,Osugi Y,Tokimasa S,Fujisaki H,Takai K,Ohta H,Kawa-Ha K,Okada S. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant 2001; 27: 977982.
  • 19
    Kussick SJ,Fromm JR,Rossini A,Li Y,Chang A,Norwood TH,Wood BL. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 2005; 124: 170181.
  • 20
    Richards SJ,Whitby L,Cullen MJ,Dickinson AJ,Granger V,Reilly JT,Hillmen P,Barnett D. Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry. Cytometry B Clin Cyto 2008; 76B: 4755.
  • 21
    Richards SJ,Rawstron AC,Hillmen P. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 2000; 42: 223233.